Extended Therapy Helps Drug-Addicted Teens

Use of detoxification medications produces noticeable results, study says

By Steven Reinberg
HealthDay Reporter

Related Encyclopedia • Acne • Alagille Syndrome • Appendicitis • Asthma in Children More... Related Healthscout Videos Picture Perfect Smile Body Dysmorphic Disorder- A Serious Disease Space Age Dental Scan Bioengineering versus Avian-Based HA? More... Related Animations • Dental Cavities More... Related Drug Information • Adderal XR • Concerta • Effexor XR • Paxil More... Related News Articles • Gender Defines Activity for Kids, Elders • Health Tip: Help Stop Thumbsucking • Family History of Aneurysm Raises Stroke Risk for Smokers • More 'Screen Time' Linked to Poor Fitness in Girls More...

TUESDAY, Nov. 4 (HealthDay News) -- Teens treated for addiction to heroin or prescription painkillers are less likely to continue using these drugs if they receive extended treatment with a combination of detoxification medications, rather than short-term drug therapy, a new study found.

Both buprenorphine and naloxone have been shown to be effective in treating opioid addiction, but only limited use of these drugs has been recommended for younger patients. Buprenorphine works by relieving withdrawal symptoms and naloxone prevents or reverses the effects of injected opioids.

Text Continues Below

---

"If you keep these young kids, average one-and-a-half years of addiction, on buprenorphine-naloxone they did a lot better," said lead study author Dr. George Woody, a professor at the University of Pennsylvania's Department of Psychiatry. "When you took them off the buprenorphine-naloxone, their opioid use went up."

Among the 15-to-21-year-olds in the study, 55 percent used heroin, 35 percent used prescription opioids such as Vicodin and Oxycontin, and 10 percent said they used both heroin and prescription painkillers, Woody said.

"Treatment programs for kids with a short addiction history have traditionally been reluctant to use the medications for anything other than short-term detoxification," Woody said. "With opioid-addicted kids you should reconsider that reluctance."

The findings are published in the Nov. 5 issue of the Journal of the American Medical Association.

For the study, Woody's team randomly assigned 152 young people to 12 weeks of treatment with buprenorphine and naloxone, or to two weeks of treatment with the same drug combination. Patients in both groups also received individual and group counseling.

The researchers found that patients receiving extended treatment had more urine tests that were positive for opioids at weeks four and eight, than at week 12. By the fourth week of treatment, 26 percent of extended-therapy patients had positive urine tests, compared to 61 percent of the short-term therapy patients.

Page:  1 | 2 | Next >>